Buy This 1 Pot Stock for a COVID-19 Breakthrough

Pot stock investors: watch this space. Cannabis stocks could get a second wind, as researchers investigate whether cannabis could be an effective treatment for COVID-19. Indeed, as the coronavirus market searches for solutions, cannabis could take centre stage. But is Aphria (TSX:APHA)(NASDAQ:APHA) the best stock to buy for this eventuality? Let’s discuss this compelling new thesis. Researchers are getting cannabinoid…

Read More

TFSA Investors: 3 Reasons to Buy Aphria Stock Today

Cannabis firm Aphria’s (TSX:APHA)(NASDAQ:APHA) stock price rallied to close 9% higher on Monday after W. Andrew Carter, a respected equity analyst at Stifel Financial, upgraded the top marijuana stock from a Hold to a Buy and increased his price target. The analyst’s US$5.90 new price target on APHA shares implied a 26% upside from the company’s previous share price at…

Read More

Is Aurora Cannabis (TSX:ACB) Stock a Buy Right Now?

Big changes keep happening at Aurora Cannabis (TSX:ACB)(NYSE:ACB) this year. The marijuana producer has significantly restructured its operations and balance sheet as industry focus turns from growth to profitability. The big question for investors is whether Aurora Cannabis stock is a buy or sell after the latest restructuring update announced on Tuesday. What’s happening at Aurora Cannabis? Aurora is suspending…

Read More

My Top Cannabis Pick

This recent market turmoil has resulted in what I can only describe as a tectonic shift in the Canadian cannabis sector. Investors have moved from a growth-at-any-cost, risk-seeking base of retail investors to a much more conservative, long-term group of investors. Stock prices tell this story. In this article, I’m going to discuss why, despite more downside likely on the…

Read More

2 Pot Stocks to Buy in June

Pot stocks had a wild ride last decade. We saw the near-instant formulation of billion-dollar markets. Several upstarts attained $1 billion valuations within weeks, despite having little to no operating history. Then, almost as suddenly, the market experienced a precipitous fall. Marijuana ETFs were cut in half last year. Many pot producers are now on the brink of bankruptcy. Yet…

Read More

Canopy Growth (TSX:WEED) Stock: Is the End Near?

If there’s one industry that has been incredibly frustrating for investors of late, it’s the cannabis industry. Canopy Growth (TSX:WEED)(NYSE:CGC) in particular used to be the darling of the industry, but that has all changed. WEED stock plummeted from all-time highs back in October 2018 after legalization. Since then, WEED stock has struggled to get anywhere near those highs again. Then, the…

Read More

Aphria (TSX:APHA): 4 Takeaways From Latest Q3 2020 Earnings

Marijuana firm Aphria’s (TSX:APHA)(NYSE:APHA) stock price surged in early trading on Wednesday. The cause was the release of its latest earnings results for its fiscal third-quarter 2020, which ended in February. Aphria was one of the most closely watched cannabis stocks in April for its potential to deliver strong financial results, and it did just that. Quarterly revenue at $144.4…

Read More

Why Did HEXO’s Stock Price Fall 26% on Wednesday?

Canadian marijuana producer HEXO‘s (TSX:HEXO)(NYSE:HEXO) stock price fell more than 26% on Wednesday as investors reacted to a news release the company issued that morning. What happened? HEXO announced a $40 million underwritten public offering of its common stock early on Wednesday. The latest offering was priced at $0.77 per share. This is a 20% discount to the previous day’s closing…

Read More

Will Cronos (TSX:CRON) Stock Fall Below $5?

Cronos Group (TSX:CRON)(NASDAQ:CRON) was once the hottest pot company in the world. From late 2014 to early 2019, Cronos stock rose in value by nearly 4,000%. The marijuana bear market of 2019 changed everything. Last year, virtually every pot stock lost more than 50% of its value. Cronos went from a $12 billion company to a valuation of less than…

Read More

Canopy Growth Stock Lagged the TSX by 5.7% in March

Canopy Growth (TSX:WEED)(NYSE:CGC) stock price was already in the throes of despair before the coronavirus crisis. The stock had already fallen dramatically from late 2018/early 2019 highs as the cannabis bubble burst. In March, Canopy Growth stock price continued to underperform the TSX, lagging it by 5.7%. During the month of March, all eyes were on developments related to the…

Read More